Published in Ann Hepatol on March 31, 2008
Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology (2009) 1.62
Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab (2009) 1.30
Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol (2009) 1.02
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection. Int J Endocrinol (2014) 0.84
Association of interferon-alpha and ribavirin-induced thyroid dysfunction with severity of disease and response to treatment in pakistani asian patients of chronic hepatitis C. Hepat Res Treat (2012) 0.79
Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients. Exp Ther Med (2014) 0.79
Hypothyroidism in Noninterferon Treated-HCV Infected Individuals Is Associated with Abnormalities in the Regulation of Th17 Cells. Hepat Res Treat (2010) 0.77
The impact of thyroid hormones on patients with hepatocellular carcinoma. PLoS One (2017) 0.75
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology (2015) 3.96
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Opportunities to use drugs and stages of drug involvement outside the United States: Evidence from the Republic of Chile. Drug Alcohol Depend (2009) 1.13
Parental monitoring at age 11 and smoking initiation up to age 17 among Blacks and Whites: a prospective investigation. Nicotine Tob Res (2009) 0.96
Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol (2006) 0.86
Student performance on smoking cessation counseling with standardized patients. Fam Med (2011) 0.84
Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks. J Med Virol (2008) 0.82
Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy. J Clin Virol (2006) 0.82
Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study. J Hepatol (2007) 0.79
Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients. Dig Dis Sci (2006) 0.79
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci (2005) 0.77
Behavioral problems and the occurrence of tobacco, cannabis, and coca paste smoking in Chile: evidence based on multivariate response models for school survey data. Drug Alcohol Depend (2009) 0.77
Incidence of Multiple Sclerosis in Puerto Rico, 2014: A Population-Based Study. Neuroepidemiology (2017) 0.75
Evolution of faculty affairs and faculty development offices in U.S. medical schools: a 10-year follow-up survey. Acad Med (2013) 0.75